Literature DB >> 24812163

Approaches to uremia.

Timothy W Meyer1, Thomas H Hostetter2.   

Abstract

The development of dialysis was a dramatic step forward in medicine, allowing people who would soon have died because of lack of kidney function to remain alive for years. We have since found, however, that the "artificial kidney" does not live up fully to its name. Dialysis keeps patients alive but not well. Part of the residual illness that dialysis patients experience is caused by retained waste solutes that dialysis does not remove as well as native kidney function does. New means are available to identify these toxic solutes, about which we currently know remarkably little, and knowledge of these solutes would help us to improve therapy. This review summarizes our current knowledge of toxic solutes and highlights methods being explored to identify additional toxic solutes and to enhance the clearance of these solutes to improve patient outcomes.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  chronic dialysis; urea; uremia

Mesh:

Substances:

Year:  2014        PMID: 24812163      PMCID: PMC4178448          DOI: 10.1681/ASN.2013121264

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  62 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

2.  Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man.

Authors:  R D Porter; W F Cathcart-Rake; S H Wan; F C Whittier; J J Grantham
Journal:  J Lab Clin Med       Date:  1975-05

3.  Increase of physical activity level after successful renal transplantation: a 5 year follow-up study.

Authors:  H Nielens; T M Lejeune; A Lalaoui; J P Squifflet; Y Pirson; E Goffin
Journal:  Nephrol Dial Transplant       Date:  2001-01       Impact factor: 5.992

4.  Two lectures on renal physiology.

Authors:  E K Marshall
Journal:  Physiologist       Date:  1966-11

5.  Studies on the pathogenesis of uremia. Comparative determinations of glucuronic acid, indican, free and bound phenols in the serum, cerebrospinal fluid, and urine of renal diseases with and without uremia.

Authors:  D Müting
Journal:  Clin Chim Acta       Date:  1965-11       Impact factor: 3.786

Review 6.  Uremic toxicity: urea and beyond.

Authors:  T A Depner
Journal:  Semin Dial       Date:  2001 Jul-Aug       Impact factor: 3.455

Review 7.  Functional adaptation to reduction in renal mass.

Authors:  J P Hayslett
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

8.  Effect of dialysis dose and membrane flux in maintenance hemodialysis.

Authors:  Garabed Eknoyan; Gerald J Beck; Alfred K Cheung; John T Daugirdas; Tom Greene; John W Kusek; Michael Allon; James Bailey; James A Delmez; Thomas A Depner; Johanna T Dwyer; Andrew S Levey; Nathan W Levin; Edgar Milford; Daniel B Ornt; Michael V Rocco; Gerald Schulman; Steve J Schwab; Brendan P Teehan; Robert Toto
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

9.  The effect of uremia on penicillin flux between blood and cerebrospinal fluid.

Authors:  R Spector; S R Snodgrass
Journal:  J Lab Clin Med       Date:  1976-05

10.  Electroencephalographic and other neurophysiological abnormalities in uremia.

Authors:  P E Teschan
Journal:  Kidney Int Suppl       Date:  1975-01       Impact factor: 10.545

View more
  24 in total

1.  Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.

Authors:  Tariq Shafi; Neil R Powe; Timothy W Meyer; Seungyoung Hwang; Xin Hai; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2016-07-19       Impact factor: 10.121

2.  Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.

Authors:  Tariq Shafi; Thomas H Hostetter; Timothy W Meyer; Seungyoung Hwang; Xin Hai; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2017-01-12       Impact factor: 8.860

3.  Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.

Authors:  Tariq Shafi; Tammy L Sirich; Timothy W Meyer; Thomas H Hostetter; Natalie S Plummer; Seungyoung Hwang; Michal L Melamed; Tanushree Banerjee; Josef Coresh; Neil R Powe
Journal:  Kidney Int       Date:  2017-07-21       Impact factor: 10.612

4.  Blood Microbiome in CKD: Should We Care?

Authors:  Robert D Mair; Tammy L Sirich
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-08       Impact factor: 8.237

Review 5.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

6.  Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.

Authors:  Matthew B Rivara; Leila R Zelnick; Andrew N Hoofnagle; Rick Newitt; Russell P Tracy; Mario Kratz; David S Weigle; Bryan R Kestenbaum
Journal:  Clin Chem       Date:  2017-02-10       Impact factor: 8.327

7.  Asymmetric dimethylarginine, erythropoietin resistance, and anemia in CKD.

Authors:  Tammy L Sirich; Glenn M Chertow
Journal:  Ann Transl Med       Date:  2019-07

Review 8.  Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.

Authors:  David A Drew; Daniel E Weiner; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

9.  Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis.

Authors:  Manjula Kurella Tamura; Glenn M Chertow; Thomas A Depner; Allen R Nissenson; Brigitte Schiller; Ravindra L Mehta; Sai Liu; Tammy L Sirich
Journal:  J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 10.121

Review 10.  Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.

Authors:  Daniel Y Li; W H Wilson Tang
Journal:  Semin Nephrol       Date:  2018-03       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.